These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15997912)

  • 1. CHART in non-small-cell lung cancer: INCHing forward.
    Hatton M; Stephens R
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):207-9. PubMed ID: 15997912
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist.
    Van Houtte P
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of inoperable non-small cell lung cancer: induction chemotherapy or hyperfractionated radiotherapy? Apropos of 2 recent therapeutic trials].
    Reboul F; Vincent P; Chauvet B; Brewer Y; Taulelle M
    Cancer Radiother; 1998; 2(3):287-9. PubMed ID: 9749128
    [No Abstract]   [Full Text] [Related]  

  • 4. In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim!
    Beitler JJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1460; author reply 1460-1. PubMed ID: 12654462
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation therapy for non-small cell lung cancer (NSCLC).
    Choy H; Chakravarthy A; Kim JS
    Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiotherapy for locally advanced non-small cell lung cancer.
    Girard N; Mornex F
    Eur J Cancer; 2009 Sep; 45 Suppl 1():113-25. PubMed ID: 19775610
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer.
    Kirkbride P; Hatton M; Lorigan P; Joyce P; Fisher P
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):361-6. PubMed ID: 12555874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined modality treatment for non-small cell lung cancer].
    Ueoka H; Tabata M
    Nihon Rinsho; 2002 May; 60 Suppl 5():455-8. PubMed ID: 12101713
    [No Abstract]   [Full Text] [Related]  

  • 10. Locally advanced non-small cell lung cancer.
    Cohen EE; Vokes EE
    Curr Treat Options Oncol; 2001 Feb; 2(1):27-42. PubMed ID: 12057138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker of treatment failure.
    Andre F; Grunewald D; Le Chevalier T
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):403. PubMed ID: 11174760
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress in unresectable stage III non-small cell lung cancer.
    Vokes EE
    Cancer J Sci Am; 1996; 2(6):304-6. PubMed ID: 9166548
    [No Abstract]   [Full Text] [Related]  

  • 13. Reasons for the slow implementations of CHART for patients with non-small cell lung cancer in clinical practice.
    Ball DL; Peters LJ; Smith J
    Radiother Oncol; 2001 Jan; 58(1):89-90. PubMed ID: 11258342
    [No Abstract]   [Full Text] [Related]  

  • 14. [Place of radiotherapy in treatment of non small cell lung cancer].
    Chmielewska E; Jodkiewicz Z
    Pneumonol Alergol Pol; 2002; 70(1-2):110-6. PubMed ID: 12148171
    [No Abstract]   [Full Text] [Related]  

  • 15. CHART and chemotherapy.
    Saunders MI
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):331-2. PubMed ID: 12206650
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in the Treatment of Lung Cancer: What's New? Not Much.
    Edelman MJ
    JAMA Oncol; 2017 Mar; 3(3):301-302. PubMed ID: 27812684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit of active treatment in non-small-cell lung cancer in elderly patients and patients with poor performance status.
    Lee D
    Clin Lung Cancer; 2003 Sep; 5(2):86-9. PubMed ID: 14596690
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-five years of treating advanced NSCLC: what have we achieved?
    Giaccone G
    Ann Oncol; 2004; 15 Suppl 4():iv81-3. PubMed ID: 15477340
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer.
    Saunders MI; Rojas A; Lyn BE; Wilson E; Phillips H
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):352-60. PubMed ID: 12555873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.